AI chatbot could be a lifeline for sarcoma patients
NCT ID NCT07505732
First seen Apr 04, 2026 · Last updated May 16, 2026 · Updated 5 times
Summary
This study is testing a new AI chatbot designed to answer questions from people with sarcoma, a type of cancer. About 78 patients will use the chatbot for one month to see if it helps them feel less anxious and more satisfied with the information they get. The goal is to see if the chatbot is easy to use and helpful for patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.